Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apyx Medical CorpAPYX · Entity 6609 | Director | August 08, 2024 | August 12, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apyx Medical Corp
Report date August 08, 2024 · Filed August 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Option to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.02 · Expires 2034-08-08 | Direct | 17,000 |
Reported balance
After 2024-08-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-08-08 · Grant · Disposed 17,000 · Balance 17,000 F1: Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2024 Filed Aug 12, 2024 20:50 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001493152-24-031315 · ownership.xml · derivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2034-08-08 F1 · derivative.exercise_date: Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant. Read SEC document |
| August 10, 2023 Filed Aug 15, 2023 16:27 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001493152-23-028917 · ownership.xml · derivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-08-10 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| June 06, 2023 Filed Jun 9, 2023 16:06 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock Option (Option to Buy) · Derivative | 10,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0000719135-23-000030 · wk-form4_1686326764.xml · derivative · entry 2 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2023 Filed Jun 9, 2023 16:06 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 10,000 | $2.79 | $27,900.00 |
DisclosureSEC source: 0000719135-23-000030 · wk-form4_1686326764.xml · nonDerivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2022 Filed Aug 17, 2022 19:30 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0000719135-22-000065 · wf-form4_166076461523529.xml · derivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2032-08-11 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| July 06, 2022 Filed Jul 11, 2022 14:22 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock Option (Option to Buy) · Derivative | 4,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0000719135-22-000050 · wf-form4_165754933810176.xml · derivative · entry 2 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2022-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Reporting Person was granted a stock option that vested and became exercisable over 3 years at a rate of 33.33% of the option on the anniversary date of each succeeding year. Read SEC document |
| July 06, 2022 Filed Jul 11, 2022 14:22 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 4,000 | $2.54 | $10,160.00 |
DisclosureSEC source: 0000719135-22-000050 · wf-form4_165754933810176.xml · nonDerivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2022 Filed May 19, 2022 17:23 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock Option (Option to Buy) · Derivative | 6,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0000719135-22-000035 · wf-form4_165298097538280.xml · derivative · entry 2 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2022 Filed May 19, 2022 17:23 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 6,000 | $2.79 | $16,740.00 |
DisclosureSEC source: 0000719135-22-000035 · wf-form4_165298097538280.xml · nonDerivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 11, 2021 17:57 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $9.42 | $0.00 |
DisclosureSEC source: 0000719135-21-000053 · wf-form4_162870464267107.xml · derivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-08-06 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 20:08 UTC | Apyx Medical Corp APYX · Entity 6609 | OtherStock Option (Option to Buy) · Derivative | 7,500 | $2.81 Strike: $2.81 | $21,075.00 |
DisclosureSEC source: 0000719135-21-000020 · wf-form4_161523410014566.xml · derivative · entry 2 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-03-18 F1 · kind: The transactions reported reflect the exercise of stock options. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 20:08 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 7,500 | $2.81 | $21,075.00 |
DisclosureSEC source: 0000719135-21-000020 · wf-form4_161523410014566.xml · nonDerivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported reflect the exercise of stock options. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:22 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $4.98 Strike: $4.98 | $84,660.00 |
DisclosureSEC source: 0000719135-20-000062 · wf-form4_159709452405554.xml · derivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2030-08-06 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:34 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0000719135-19-000029 · wf-form4_156503723764738.xml · derivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2029-08-01 F1 · derivative.exercise_date: Reporting person was granted a stock option in accordance with the director compensation plan which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| August 30, 2018 Filed Sep 10, 2018 15:33 UTC | Apyx Medical Corp BVX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 24,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0000719135-18-000067 · wf-form4_153659357019343.xml · derivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2028-08-29 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| September 14, 2017 Filed Sep 27, 2017 13:00 UTC | Apyx Medical Corp BVX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 12,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0000719135-17-000044 · wf-form4_150651723234414.xml · derivative · entry 1 Geraghty Michael · CIK 0001516359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-09-13 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.